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Abstract
Background: Distribution of body fat is more important than the amount of fat as a prognostic factor for life expectancy.
Despite that, body mass index (BMI) still holds its status as the most used indicator of obesity in clinical work.
Methods: We assessed the association of five different anthropometric measures with mortality in general and
cardiovascular disease (CVD) mortality in particular using Cox proportional hazards models. Predictive properties were
compared by computing integrated discrimination improvement and net reclassification improvement for two different
prediction models. The measures studied were BMI, waist circumference, hip circumference, waist-to-hip ratio (WHR), and
waist-to-height ratio (WHtR). The study population was a prospective cohort of 62,223 Norwegians, age 20–79, followed up
for mortality from 1995–1997 to the end of 2008 (mean follow-up 12.0 years) in the Nord-Trøndelag Health Study (HUNT 2).
Results: After adjusting for age, smoking and physical activity WHR and WHtR were found to be the strongest predictors of
death. Hazard ratios (HRs) for CVD mortality per increase in WHR of one standard deviation were 1.23 for men and 1.27 for
women. For WHtR, these HRs were 1.24 for men and 1.23 for women. WHR offered the greatest integrated discrimination
improvement to the prediction models studied, followed by WHtR and waist circumference. Hip circumference was in
strong inverse association with mortality when adjusting for waist circumference. In all analyses, BMI had weaker association
with mortality than three of the other four measures studied.
Conclusions: Our study adds further knowledge to the evidence that BMI is not the most appropriate measure of obesity in
everyday clinical practice. WHR can reliably be measured and is as easy to calculate as BMI and is currently better
documented than WHtR. It appears reasonable to recommend WHR as the primary measure of body composition and
obesity.
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Introduction
It is well documented that distribution of body fat is more
important than the amount of fat as a prognostic factor for
metabolic disturbance, cardiovascular diseases (CVD) and life
expectancy [1–6]. Central or abdominal fat has been associated
with the highest risk [7], with visceral fat being of special
importance [8,9]. Increased waist-to-hip ratio (WHR) as a risk
factor for CVD and mortality was first reported from the Swedish
population studies in Gothenburg in 1984 where WHR was shown
to be a stronger prognostic factor than body mass index (BMI)
[3,4]. These results have repeatedly been confirmed since [10–14].
The specific protective effect of increased peripheral (lower body)
fat in the form of hip and thigh [15] circumference in contrast to
waist girth has also been reported [9], both for men [13,16] and
women [17,18]. The more recent measure waist-to-height ratio
(waist circumference divided by height [WHtR]) disregards the
peripheral fat but takes the height into account. Some researchers
have found WHtR to be an even stronger predictor of death, CVD
[19–22] and CVD risk factors [23,24] than the above mentioned
measures. Others have suggested the difference of these anthro-
pometric measures to be insignificant or none at all, regarding
predictive ability for CVD [25,26].
In recent years an increasing amount of knowledge has been
gathered regarding the metabolic basis for the special importance of
central fat distribution. Various metabolic, endocrine and neural
factors appear to influence where the body fataccumulates and how
this affects the individual’s physiology and disease risk [5,8,9,27].
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of the world [28–32], there has been a debate about which
anthropometric measures are best suited to define and monitor
obesity for medical purposes. Despite the evidence of abdominal
obesity being far more important than body weight regarding
mortality and CVD, definitions of overweight and obesity based
on BMI continue to be the most widely used measures in
publications, including clinical guidelines designed for individual,
preventive or therapeutic counselling [28,33–35]. Many guidelines
mention WHR and/or waist circumference as interchangeable
with BMI although the correlation is questionable [10,11,21,23].
This practical approximation decreases the specificity of the
obesity definition and undermines the predictive precision of CVD
risk estimates.
The aim of this study was to further clarify the associations of
anthropometric indicators of obesity and body composition (BMI,
WHR, WHtR, waist circumference, and hip circumference) with
overall mortality, and specifically with CVD mortality.
Methods
Study population
All adults aged 20 years or older and living in Nord-Trøndelag
County in Norway were in 1995 to 1997 invited to participate at
the second wave of the Nord-Trøndelag Health Study (HUNT 2).
Overall, 74% of women (34,786) and 65% of men (30,575) chose
to participate. The HUNT 2 population is ethnically homogenous
(dominated by individuals of Nordic origin) and has been
considered representative of the total Norwegian population
regarding demography, socio-economic factors, morbidity and
mortality, including mortality from CVD [36]. The HUNT 2
study has been described in detail elsewhere [36] (see www.ntnu.
no/hunt/english).
For the purpose of the present analysis, 3,138 participants aged
80 years or more at baseline (1,231 men and 1,907 women) were
excluded. Individuals with established CVD at baseline (self-
reported myocardial infarction, stroke or angina pectoris) were
excluded, 4,571 in total (2,780 men and 1,791 women), as well as
681 person with missing data on one or more of the following
variables: height, weight, waist circumference, and hip circumfer-
ence. Our calculations are thus based on information from 56,971
individuals (26,461 men and 30,510 women) aged 20–79 years
who were without any known CVD at baseline. Baseline
characteristics are depicted in the supporting information (Table
S1).
Study variables
In the HUNT 2 study, height and weight were measured with
participants wearing light clothes without shoes; height to the
nearest 1.0 cm and weight to the nearest 0.5 kg. Based on these
measures we calculated BMI as weight in kg divided by the
squared value of height in meters. Waist and hip circumferences
were measured with a steel band to the nearest 1.0 cm with the
participant standing and with the arms hanging relaxed. The waist
circumference was measured horizontally at the height of the
umbilicus, and the hip circumference was measured likewise at the
thickest part of the hip [36]. When analysing the anthropometric
measures, we aimed at using clinically recognisable categorisa-
tions, rather than percentiles. BMI was categorised according to
WHO definitions [28], the waist circumference categories were
defined with 10 cm interval, and the hip circumference categories
with 5 cm interval. The WHR and WHtR were, however,
categorised by quintiles.
In the present analysis smoking was defined as daily smoking of
cigarettes, cigars or a pipe. Smoking status was defined as
unknown, current smoker, former, or never smoker. Levels of
recreational physical activity were defined as self-reported number
of hours spent on hard or light activity during one week: no
activity; ,3 h light activity; $3 h light activity or ,1 h hard
activity; $1 h hard activity; unknown.
Follow-up
The personal identity number of Norwegian citizens enabled
linkage of HUNT 2 participant data to the Cause of Death
Registry at Statistics Norway (information on www.ssb.no/
english/). For the present analysis, each participant contributed
person-time from the date of clinical examination (August 1995–
June 1997) until the date of death or end of follow-up (December
31
st 2008). The mean follow-up time was 12.0 years, in total
684,644 person-years. Death from CVD was defined by the
International Classification of Disease code for the primary
diagnosis of death (ICD-9: 390–459; ICD-10: I 00-I 99).
Ethics statement
Each participant in the HUNT study signed a written consent
regarding the screening and the use of data for research purposes
as well as to linking their data to other registers (subject to
approval of the Norwegian Data Inspectorate). The study was
approved by the Norwegian Data Inspectorate and by the
Regional Committee for Ethics in Medical Research.
Statistical analysis
We used Cox proportional hazard models to compute hazard
ratios (HRs) for overall mortality and CVD mortality associated
with different levels of each anthropometric measure. Precision of
the estimated associations was assessed by a 95% confidence
interval. Departure from the proportional hazards assumption was
evaluated by Schoenfeld residuals and log-minus-log plots. An
interaction term between time and the appropriate variables was
added to the model if the proportional hazards assumption did not
hold.
We analysed the HR for participants with BMI below 18.5 kg/
m
2 (104 men and 314 women) for comparison with the other BMI
categories but excluded them from further analysis due to the
potential of reverse causality (a J-shaped mortality curve) [37,38].
We calculated sex specific standard deviation (SD) scores for
each of the anthropometric variables and estimated the HR
associated with an increase of one SD.
We analysed the data separately for men and women, and all
associations were adjusted for potential confounding effects of age,
smoking status and recreational physical activity. We conducted
sensitivity analyses involving three additional models (Model 2–4).
Model 2 included the same covariates as the main model but
excluded participants with unknown smoking status. Model 3 was
adjusted for age, smoking, and physical activity (as our main
model) in addition to self-reported diabetes mellitus and weekly
alcohol consumption (abstinence, 0–2 glasses [units], 2.1–5 glasses,
5.1–8 glasses, .8 glasses). Model 4 was identical to our main
model but excluded the first three years of follow-up to limit the
reverse causality effect of undiagnosed diseases.
The ‘‘relative informativeness’’ of each anthropometric measure
was evaluated by examining the contributions made to the x
2
likelihood ratio statistic in the Cox regression model compared
with a model that only contained the confounders, as the x
2
statistic can be used as a measure of the improvement of goodness
of fit [39]. This was done both in relation with all cause and CVD
mortality, respectively.
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anthropometric measures for CVD death, sex-specific net
reclassification improvement (NRI) and integrated discrimination
improvement (IDI) were computed when adding each anthropo-
metric measure to two different prediction models. Model A
included age as the only predictive variable, while Model B
included age, smoking status, systolic blood pressure, and total
cholesterol. For each model three different NRI calculations were
done, using two (,5%, $5%), three (,1%, 1–9%, $10%), and
four (,1%, 1–4%, 5–9%, $10%) levels of risk of CVD death,
respectively.
In addition, we conducted an analysis of the anthropometric
measures stratified by age (above and below 60 years). Finally,
mutually adjusted analyses were conducted for waist and hip
circumference, as well as for BMI and WHR.
All statistical tests were two-sided and all analyses were
performed using Stata for Windows (Version 11 StataCorp LP,
TX, USA).
Results
We present the risk of death from all causes and from CVD
among men and women aged 20–79 (Tables 1 and 2) with
absolute numbers and HRs in association with each of the
anthropometric measures studied, after adjusting for age, smoking
and physical activity. For men, WHR and WHtR had the highest
(and similar) predictive power, both regarding mortality from
CVD and from all causes, followed by waist circumference
(Table 1). BMI had considerably weaker association, with HRs
only reaching statistical significance for death from CVD but not
overall mortality.
All cause mortality was for both sexes statistically significantly
lower in the BMI range 25.0–29.9 compared to the reference
group (BMI 18.5–24.9), given the above adjustments.
Overall the results were similar for both sexes except for WHR
appearing as a somewhat stronger predictor among women, as
compared to men, while HRs for WHtR seemed more comparable
with that of waist circumference than WHR (Table 2). This was
apparent in both mortality categories.
The sensitivity analyses did not deviate considerably from the
primary results. Among men, the HRs per one SD increase in
anthropometric measures never differed more than 0.02 from the
main model (Table S2). Among women, adjustment for self-
reported diabetes and alcohol consumption resulted in a slight
decrease in all HRs (Table S3). The decrease was in the range of
0.04–0.06 for CVD mortality and 0.03–0.04 for total mortality.
Less deviation from the main model was seen in other parts of the
analysis.
Table 3 shows the x
2 likelihood ratio statistic for each measure.
Within brackets the informativeness is given in percentage relative
to WHR which was the most informative measure. The table
shows results from analysis of the anthropometric measures as
continuous variables. Our sensitivity analysis, examining the
measures as categorical variables, gave similar results (data not
shown).
The results from our analysis of reclassification and discrimi-
nation improvement are shown in Table 4 and Table 5. Among
men (Table 4), WHtR offered most improvement to the prediction
models studied, judging from the IDI, followed closely by WHR.
Among women (Table 5), most improvement was associated with
WHR, followed by WHtR and waist circumference. BMI and hip
circumference seemed to add little or no information to the
prediction models. Waist circumference, WHR and WHtR
alternately produced the highest NRI, depending on the model
and cut-points used. Some discordance between NRI and IDI
estimates were noted.
Risk of death from CVD associated with the measures studied
stratified by age is shown in Table 6. HRs are given both for men
and women, aged 20–59 years versus 60–79 at baseline, for each
of the measures. The strongest association was between CVD
mortality and WHtR for men and WHR for women. For all
measures the HRs were somewhat higher for the younger
stratum.
The results for CVD mortality from the mutual adjustment
analysis of hip and waist circumferences are shown in Table 7.
Adjusting for hip circumference strengthened the association of
waist girth with CVD mortality considerably for both sexes.
Increasing hip circumference, on the other hand, seemed to be
protective when adjusting for the waist. The results were similar
for all cause mortality (not shown in table). The results from a
corresponding analysis of BMI and WHR, mutually adjusted, are
shown in Table 8. Adjusting BMI for WHR attenuated the
association of BMI with mortality significantly, while adjusting
WHR for BMI had no significant effect on the association.
Discussion
Of the five anthropometric measures studied, WHR and WHtR
were most strongly associated with mortality, after adjusting for
confounding factors. This was true both regarding overall
mortality and death from CVD specifically. In accordance with
other studies, our results show that BMI is a poorer predictor of
death than the other measures [2–7,10–13,40]. These results
underscore the advantage of assessing body configuration rather
than body weight when estimating mortality risk. Furthermore,
when controlling for waist circumference, increasing hip circum-
ference appears to be protective in both genders. In our study,
obesity emerged as a more important risk factor among young
people, in comparison to older. This is in coherence with earlier
studies [41].
In all parts of our analysis, BMI showed weaker associations
with both all cause mortality and CVD mortality, when
compared to waist circumference, WHR and WHtR. Further-
more, BMI was the only among these four measures which failed
to show a statistically significant association with all cause
mortality. BMI also contributed less additional information to the
prediction models studied (Tables 4 and 5), and offered poorer
fitting models (Table 3). Hence, BMI seems to be a poorer
indicator of disease risk than the other measures studied, being
superior only to hip circumference. When adjusting for WHR,
BMI seemed even less predictive, while adjusting for BMI had no
effect on WHR mortality associations. This emphasises the
superiority of the alternative measures over BMI as indicators of
CVD risk.
Waist circumference proved to be a statistically significant risk
factor in all analyses, but still showed weaker associations with
mortality than both WHR and WHtR. In particular, it emerged as
a strong risk factor when adjusting for hip circumference. This
underlines the significance of considering body configuration
rather than the abdominal girth alone.
Hip circumference showed a weak positive association with
mortality. However, when adjusting for waist circumference, it
proved to be inversely related to CVD mortality in both genders.
This finding is in accordance with previous research [9,13,16–18].
Both in the presence (Table 6) and absence of age stratification
(Tables 1 and 2), WHR turned out to be a stronger risk factor than
WHtR among women, whilst the two measures had similar
predictive power among men. This gender difference favoured the
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that WHR and WHtR are superior to the other measures in
relation to prediction of mortality.
Based on the IDIs (Tables 4 and 5), WHR and WHtR offered
the greatest improvement to our prediction models, followed
closely by waist circumference for women. The improvement
Table 1. Risk of death from all causes and from cardiovascular disease among men aged 20–79; associations with anthropometric
measures.
All causes Cardiovascular disease
Anthropometric measures
No. of
persons
No. of
deaths
Adjusted
a
HR (95% CI) Ptrend
No. of
deaths
Adjusted
a
HR (95% CI) Ptrend
Body mass index (kg/m
2)
,18.5
b 104 31 2.48 (1.73–3.54) 9 2.23 (1.15–4.33)
18.5–24.9 9,575 970 1.00 (Reference) 300 1.00 (Reference)
25.0–29.9 13,138 1,320 0.86 (0.79–0.93) 492 1.04 (0.90–1.21)
30.0–34.9 3,154 445 1.10 (0.98–1.23) 175 1.42 (1.17–1.71)
$35.0 490 70 1.34 (1.05–1.72) 0.16 28 1.78 (1.20–2.64) ,0.001
per 5 kg/m
2 26,357 2,805 1.04 (0.98–1.10) 0.21 995 1.19 (1.08–1.30) ,0.001
per SD (3.4 kg/m
2) 26,357 2,805 1.02 (0.99–1.06) 0.21 995 1.12 (1.06–1.20) ,0.001
Waist circumference (cm)
,80 1,882 116 1.17 (0.96–1.42) 33 1.06 (0.74–1.53)
80–89 9,466 723 1.00 (Reference) 233 1.00 (Reference)
90–99 10,378 1,134 1.01 (0.92–1.11) 404 1.10 (0.93–1.29)
100–109 3,625 588 1.11 (0.99–1.24) 226 1.27 (1.05–1.53)
$110 1,006 244 1.64 (1.41–1.90) ,0.001 99 1.99 (1.56–2.53) ,0.001
per 10 cm 26,357 2,805 1.11 (1.07–1.16) ,0.001 995 1.21 (1.13–1.29) ,0.001
per SD (9.1 cm) 26,357 2,805 1.10 (1.06–1.14) ,0.001 995 1.19 (1.12–1.26) ,0.001
Hip circumference (cm)
,95 2,360 275 1.18 (1.02–1.36) 80 0.96 (0.75–1.25)
95–99 6,158 639 1.00 (Reference) 225 1.00 (Reference)
100–104 9,203 925 0.89 (0.80–0.99) 335 0.92 (0.77–1.09)
105–109 5,471 546 0.86 (0.76–0.96) 200 0.89 (0.73–1.08)
$110 3,165 420 1.17 (1.03–1.33) 0.52 155 1.23 (1.00–1.51) 0.24
per 10 cm 26,357 2,805 1.01 (0.95–1.07) 0.76 995 1.11 (1.00–1.23) 0.05
per SD (6.2 cm) 26,357 2,805 1.01 (0.97–1.05) 0.76 995 1.06 (1.00–1.13) 0.05
Waist-to-hip ratio
,0.85 5,301 254 1.07 (0.90–1.26) 75 1.11 (0.82–1.50)
0.86–0.87 5,126 328 1.00 (Reference) 97 1.00 (Reference)
0.88–0.89 5,287 493 1.12 (0.97–1.29) 167 1.25 (0.97–1.60)
0.90–0.93 5,367 646 1.14 (0.99–1.30) 233 1.33 (1.05–1.69)
$0.94 5,276 1,084 1.38 (1.21–1.56) ,0.001 423 1.70 (1.36–2.13) ,0.001
per 0.1 unit 26,357 2,805 1.28 (1.20–1.36) ,0.001 995 1.43 (1.29–1.59) ,0.001
per SD (0.06) 26,357 2,805 1.15 (1.11–1.19) ,0.001 995 1.23 (1.16–1.30) ,0.001
Waist-to-height ratio
,0.47 5,286 239 1.10 (0.93–1.30) 63 1.09 (0.79–1.50)
0.48–0.49 5,219 334 1.00 (Reference) 94 1.00 (Reference)
0.50–0.51 5,360 501 1.11 (0.96–1.27) 173 1.34 (1.04–1.72)
0.52–0.54 5,264 663 1.07 (0.94–1.23) 238 1.31 (1.03–1.67)
$0.55 5,228 1,068 1.24 (1.09–1.40) 0.005 427 1.65 (1.32–2.08) ,0.001
per 0.1 unit 26,357 2,805 1.24 (1.15–1.33) ,0.001 995 1.50 (1.33–1.68) ,0.001
per SD (0.05) 26,357 2,805 1.12 (1.08–1.16) ,0.001 995 1.24 (1.16–1.31) ,0.001
Abbreviations: HR=hazard ratio, CI=confidence interval, SD=standard deviation.
aAdjusted for age (in the time scale), smoking (never, former, current, unknown) and physical activity per week (no, ,3 hours light, $3 hours light or ,1 hour hard,
$1 hour hard, unknown).
bThis category was excluded from the remainder of the analysis presented in the table.
doi:10.1371/journal.pone.0026621.t001
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blood pressure produced IDIs in the range of 5–6% for men
and 1.7–2.5% for women, using the same models. Some
discrepancies was noted between the IDIs and the NRIs (e.g. a
negative NRI 2 for WHtR among men, Table 4). This can be
explained by the choice of cut-points in combination with low
Table 2. Risk of death from all causes and from cardiovascular disease among women aged 20–79; associations with
anthropometric measures.
All causes Cardiovascular disease
Anthropometric measures
No. of
persons
No. of
deaths
Adjusted
a
HR (95% CI) Ptrend
No. of
deaths
Adjusted
a
HR (95% CI) Ptrend
Body mass index (kg/m
2)
,18.5
b 314 44 2.02 (1.49–2.74) 9 1.39 (0.71–2.71)
18.5–24.9 13,895 819 1.00 (Reference) 230 1.00 (Reference)
25.0–29.9 10,947 872 0.81 (0.74–0.90) 308 0.93 (0.78–1.10)
30.0–34.9 3,961 469 0.93 (0.83–1.05) 181 1.10 (0.90–1.35)
$35.0 1,393 204 1.24 (1.06–1.45) 0.26 74 1.41 (1.08–1.85) 0.02
per 5 kg/m
2 30,196 2,364 1.03 (0.98–1.07) 0.27 793 1.10 (1.03–1.19) 0.009
per SD (4.5 kg/m
2) 30,196 2,364 1.02 (0.98–1.07) 0.27 793 1.09 (1.02–1.17) 0.009
Waist circumference (cm)
,70 3,981 126 1.11 (0.92–1.35) 25 0.94 (0.62–1.44)
70–79 11,122 566 1.00 (Reference) 152 1.00 (Reference)
80–89 8,589 761 1.00 (0.90–1.12) 265 1.14 (0.93–1.40)
90–99 4,330 537 1.11 (0.99–1.23) 207 1.36 (1.10–1.68)
$100 2,174 374 1.48 (1.30–1.70) ,0.001 144 1.80 (1.43–2.27) ,0.001
per 10 cm 30,196 2,364 1.11 (1.07–1.16) ,0.001 793 1.20 (1.12–1.27) ,0.001
per SD (11.3 cm) 30,196 2,364 1.13 (1.09–1.18) ,0.001 793 1.22 (1.14–1.31) ,0.001
Hip circumference (cm)
,95 6,457 348 1.10 (0.95–1.27) 96 1.17 (0.89–1.54)
95–99 6,639 428 1.00 (Reference) 115 1.00 (Reference)
100–104 6,840 499 0.86 (0.75–0.98) 173 1.04 (0.82–1.31)
105–109 4,498 410 0.87 (0.76–1.00) 151 1.07 (0.84–1.36)
$110 5,762 679 1.02 (0.90–1.15) 0.33 258 1.27 (1.01–1.58) 0.14
per 10 cm 30,196 2,364 1.03 (0.98–1.07) 0.20 793 1.10 (1.02–1.18) 0.01
per SD (9.4 cm) 30,196 2,364 1.03 (0.99–1.07) 0.20 793 1.09 (1.02–1.17) 0.01
Waist-to-hip ratio
,0.74 6,040 191 1.01 (0.84–1.22) 46 0.94 (0.65–1.35)
0.74–0.77 6,011 282 1.00 (Reference) 83 1.00 (Reference)
0.78–0.79 5,988 413 1.08 (0.93–1.26) 134 1.11 (0.84–1.46)
0.80–0.83 6,125 572 1.16 (1.00–1.34) 189 1.17 (0.90–1.51)
$0.84 6,032 906 1.48 (1.29–1.69) ,0.001 341 1.65 (1.30–2.10) ,0.001
per 0.1 unit 30,196 2,364 1.34 (1.25–1.43) ,0.001 793 1.49 (1.33–1.66) ,0.001
per SD (0.06) 30,196 2,364 1.19 (1.15–1.24) ,0.001 793 1.27 (1.18–1.36) ,0.001
Waist-to-height ratio
,0.43 6,001 156 1.29 (1.05–1.59) 30 1.29 (0.83–2.02)
0.43–0.46 6,114 235 1.00 (Reference) 55 1.00 (Reference)
0.47–0.49 6,010 407 1.19 (1.01–1.40) 121 1.35 (0.98–1.86)
0.50–0.54 6,014 606 1.15 (0.99–1.34) 218 1.42 (1.05–1.91)
$0.55 6,057 960 1.35 (1.16–1.56) 0.005 369 1.71 (1.28–2.28) ,0.001
per 0.1 unit 30,196 2,364 1.20 (1.14–1.27) ,0.001 793 1.34 (1.21–1.47) ,0.001
per SD (0.07) 30,196 2,364 1.14 (1.10–1.19) ,0.001 793 1.23 (1.15–1.32) ,0.001
Abbreviations: HR=hazard ratio, SD=standard deviation, CI=confidence interval.
aAdjusted for age (in the time scale), smoking (never, former, current, unknown) and physical activity per week (no, ,3 hours light, $3 hours light or ,1 hour hard,
$1 hour hard, unknown).
bThis category was excluded from the remainder of the analysis presented in the table.
doi:10.1371/journal.pone.0026621.t002
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highlights the importance of careful selection of cut-points,
depending on the purpose. Identification of optimal cut-points
depends on chosen background factors as well as considerations
related to clinical relevance. Our results indicate that the best
discrimination is obtained by use of waist circumference, WHR
or WHtR.
The main strength of our investigation lies in the prospective
and comprehensive nature of the HUNT 2 study, its good
participation rates, and it being fairly representative for the entire
Norwegian nation. The fact that the HUNT population is
ethnically homogenous may also be considered a strength in this
context, since ethnic differences (genetic and epigenetic factors)
may influence the predictive properties of anthropometric
measures [42–44].
The HUNT 2 database lacks comprehensive information on the
participants’ dietary habits and cancer history. However, the
exclusion of participants with BMI ,18.5 kg/m
2 and the
sensitivity analysis which excludes the first three years of follow-
up minimise the potential for confounding by cancer. Our
sensitivity analysis indicates that the impact of other potential
confounders is minimal.
Our study adds further knowledge to the evidence that BMI is
not the most appropriate measure o fo b e s i t yi ne v e r y d a yc l i n i c a l
practice. WHR is as easy to calculate as BMI and is presently
better documented than WHtR. It therefore appears reasonable
Table 3. Relative ‘‘informativeness’’ of different anthropometric measures in relation to mortality; x
2 likelihood ratio statistics for
each measure and, within brackets, percentage of x
2 for waist-to-hip ratio.
Informativeness
Anthropometric measures All cause mortality Cardiovascular disease mortality
Men
Body mass index 1.5 (3%) 13.3 (31%)
Waist circumference 26.3 (48%) 30.4 (70%)
Hip circumference 0.1 (0.2%) 3.7 (8%)
Waist-to-hip ratio 54.7 (100%) 43.5 (100%)
Waist-to-height ratio 34.4 (63%) 45.0 (104%)
Women
Body mass index 1.2 (2%) 6.6 (15%)
Waist circumference 33.4 (47%) 30.7 (69%)
Hip circumference 1.6 (2%) 6.3 (14%)
Waist-to-hip ratio 71.5 (100%) 44.4 (100%)
Waist-to-height ratio 38.7 (54%) 33.2 (75%)
doi:10.1371/journal.pone.0026621.t003
Table 4. Risk reclassification improvement among men
a; anthropometric measures and risk of death from cardiovascular disease.
Anthropometric measures IDI (%) P NRI 1
b (%) P NRI 2
c (%) P NRI 3
d (%) P
Model A
e
Body mass index 0.59 0.20 1.50 0.64 1.64 0.78 5.74 0.39
Waist circumference 1.99 0.009 4.32 0.28 1.09 0.88 9.62 0.23
Hip circumference 0.10 0.58 1.24 0.48 20.79 0.81 0.73 0.84
Waist-to-hip ratio 3.45 ,0.001 4.20 0.35 5.88 0.42 15.44 0.07
Waist-to-height ratio 3.64 ,0.001 2.86 0.52 5.39 0.47 13.37 0.12
Model B
f
Body mass index 0.40 0.42 21.94 0.61 24.16 0.39 22.41 0.69
Waist circumference 1.59 0.04 7.33 0.14 0.67 0.91 12.76 0.10
Hip circumference 0.09 0.72 20.04 0.99 4.20 0.27 5.78 0.21
Waist-to-hip ratio 2.63 0.007 3.69 0.46 4.32 0.53 13.64 0.11
Waist-to-height ratio 2.77 0.005 7.23 0.17 26.18 0.36 6.84 0.43
Abbreviations: IDI=integrated discrimination improvement, NRI=net reclassification improvement.
aParticipants with body mass index ,18.5 kg/m
2 were excluded from the analysis.
bNRI when adding a given anthropometric measure to a prediction model using two risk categories (,5%, $5%).
cThree risk categories (,1%, 1–9%, $10%).
dFour risk categories (,1%, 1–4%, 5–9%, $10%).
eVariable included in model: Age.
fVariables included in model: Age, smoking status, systolic blood pressure, and total cholesterol.
doi:10.1371/journal.pone.0026621.t004
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composition and obesity, at least when it comes to assessing
risk of CVD. There is, however, need for further clarification
before determining whether WHtR should be considered an
even better alternative than WHR. Single (waist circumference
in isolation) or additional measures (involving weight and/or
height) may also be added to nuance estimations of CVD risk
when indicated, for instance in relation to clearly obese or
Table 5. Risk reclassification improvement among women
a; anthropometric measures and risk of death from cardiovascular
disease.
Anthropometric measures IDI (%) P NRI 1
b (%) P NRI 2
c (%) P NRI 3
d (%) P
Model A
e
Body mass index 0.94 0.07 0.28 0.95 28.41 0.23 26.63 0.43
Waist circumference 4.12 ,0.001 2.73 0.67 8.42 0.37 15.00 0.19
Hip circumference 1.12 0.03 20.98 0.81 27.35 0.28 27.38 0.35
Waist-to-hip ratio 5.01 ,0.001 2.15 0.77 26.76 0.009 32.21 0.01
Waist-to-height ratio 4.36 ,0.001 24.39 0.51 10.77 0.26 9.10 0.43
Model B
f
Body mass index 0.84 0.15 23.27 0.42 5.90 0.35 5.36 0.48
Waist circumference 3.46 0.002 7.09 0.26 30.25 0.001 43.01 ,0.001
Hip circumference 1.11 0.07 22.80 0.53 6.36 0.34 6.98 0.38
Waist-to-hip ratio 3.90 0.002 23.95 0.49 33.30 ,0.001 36.08 ,0.001
Waist-to-height ratio 3.65 0.001 4.37 0.47 25.41 0.006 35.50 0.001
Abbreviations: IDI=integrated discrimination improvement, NRI=net reclassification improvement.
aParticipants with body mass index ,18.5 kg/m
2 were excluded from the analysis.
bNRI when adding a given anthropometric measure to a prediction model using two risk categories (,5%, $5%).
cThree risk categories (,1%, 1–9%, $10%).
dFour risk categories (,1%, 1–4%, 5–9%, $10%).
eVariable included in model: Age.
fVariables included in model: Age, smoking status, systolic blood pressure, and total cholesterol.
doi:10.1371/journal.pone.0026621.t005
Table 6. Risk of death from cardiovascular disease among men and women aged 20–79 years
a; associations with anthropometric
measures stratified by age at baseline.
Adjusted
b HR (95% CI)
Men Women
Anthropometric measures 20–59 years 60–79 years 20–59 years 60–79 years
Body mass index, per 5 kg/m
2 1.55 (1.27–1.89) 1.11 (1.00–1.23) 1.26 (0.97–1.64) 1.09 (1.01–1.18)
Waist circumference, per 10 cm 1.49 (1.28–1.74) 1.15 (1.07–1.24) 1.36 (1.12–1.66) 1.18 (1.10–1.26)
Hip circumference, per 10 cm 1.45 (1.14–1.84) 1.04 (0.93–1.17) 1.12 (0.86–1.47) 1.09 (1.01–1.18)
Waist-to-hip ratio, per 0.1 unit 1.96 (1.52–2.53) 1.35 (1.20–1.51) 2.15 (1.60–2.89) 1.42 (1.26–1.60)
Waist-to-height ratio, per 0.1 unit 2.25 (1.73–2.93) 1.37 (1.21–1.55) 1.69 (1.23–2.33) 1.30 (1.18–1.44)
Per one SD increase
Body mass index
c 1.35 (1.18–1.55) 1.08 (1.00–1.15) 1.23 (0.97–1.56) 1.08 (1.01–1.16)
Waist circumference
d 1.44 (1.26–1.66) 1.14 (1.06–1.22) 1.42 (1.14–1.77) 1.20 (1.12–1.30)
Hip circumference
e 1.25 (1.08–1.45) 1.03 (0.96–1.10) 1.11 (0.86–1.44) 1.09 (1.01–1.17)
Waist-to-hip ratio
f 1.47 (1.27–1.69) 1.18 (1.11–1.26) 1.58 (1.33–1.89) 1.24 (1.15–1.33)
Waist-to-height ratio
g 1.54 (1.34–1.76) 1.18 (1.10–1.26) 1.46 (1.16–1.84) 1.21 (1.13–1.30)
Abbreviations: HR=hazard ratio, SD=standard deviation, CI=confidence interval.
aParticipants with body mass index ,18.5 kg/m
2 were excluded from the analyses.
bAdjusted for age (in the time scale), smoking (never, former, current, unknown) and physical activity per week (no, ,3 hours light, $3 hours light or ,1 hour hard,
$1 hour hard, unknown).
cOne SD: men 3.5 kg/m
2, women 4.5 kg/m
2.
dOne SD: men 9.2 cm, women 11.5 cm.
eOne SD: men 9.2 cm, women 9.4 cm.
fOne SD: 0.06 for both sexes.
gOne SD: men 0.05, women 0.07.
doi:10.1371/journal.pone.0026621.t006
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weakness of the approach suggested here is the documented,
inter-personal variance in measurement of waist and hip
circumferences [45]. This problem can be addressed by
standardised measurement procedures [46] and adequate
training [45].
Table 7. Risk of death from cardiovascular disease among men and women aged 20–79 years
a; associations with waist and hip
circumferences mutually adjusted.
Men Women
Anthropometric measures
No. of
persons
No. of
deaths
Adjusted
b
HR (95% CI)
No. of
persons
No. of
deaths
Adjusted
b
HR (95% CI)
Waist circumference (cm)
Men Women
,80 ,70 1,882 33 0.98 (0.67–1.42) 3,981 25 0.86 (0.56–1.32)
80–89 70–79 9,466 233 1.00 (Reference) 11,122 152 1.00 (Reference)
90–99 80–89 10,378 404 1.20 (1.00–1.44) 8,589 265 1.26 (1.02–1.56)
100–109 90–99 3,625 226 1.52 (1.20–1.93) 4,330 207 1.65 (1.28–2.14)
$110 $100 1,006 99 2.64 (1.91–3.67) 2,174 144 2.54 (1.81–3.58)
Waist circumference, per 10 cm 26,357 995 1.42 (1.28–1.58) 30,196 793 1.44 (1.29–1.61)
Hip circumference (cm)
,95 2,360 80 1.16 (0.89–1.50) 6,457 96 1.40 (1.06–1.84)
95–99 6,158 225 1.00 (Reference) 6,639 115 1.00 (Reference)
100–104 9,203 335 0.75 (0.63–0.90) 6,840 173 0.88 (0.69–1.12)
105–109 5,471 200 0.61 (0.49–0.76) 4,498 151 0.77 (0.60–1.01)
$110 3,165 155 0.65 (0.49–0.86) 5,762 258 0.67 (0.50–0.91)
Hip circumference, per 10 cm 26,357 995 0.73 (0.62–0.86) 30,196 793 0.77 (0.68–0.88)
Abbreviations: HR=hazard ratio, CI=confidence interval.
aParticipants with body mass index ,18.5 kg/m
2 were excluded from all analyses.
bAdjusted for age (in the time scale), smoking (never, former, current, unknown), physical activity per week (no, ,3 hours light, $3 hours light or ,1 hour hard,
$1 hour hard, unknown), and either waist circumference or hip circumference.
doi:10.1371/journal.pone.0026621.t007
Table 8. Risk of death from cardiovascular disease among men and women aged 20–79 years
a; associations with body mass index
and waist-to-hip ratio mutually adjusted.
Men Women
Anthropometric measures No. of persons No. of deaths Adjusted
b HR (95% CI) No. of persons No. of deaths Adjusted
b HR (95% CI)
Body mass index (kg/m
2)
18.5–24.9 9,575 300 1.00 (Reference) 13,895 230 1.00 (Reference)
25.0–29.9 13,138 492 0.91 (0.78–1.07) 10,947 308 0.81 (0.68–0.97)
30.0–34.9 3,154 175 1.08 (0.87–1.34) 3,961 181 0.88 (0.71–1.08)
$35.0 490 28 1.23 (0.81–1.86) 1,393 74 1.07 (0.81–1.42)
per SD (M: 3.4, W: 4.5) 26,357 995 1.01 (0.94–1.09) 30,196 793 1.00 (0.93–1.08)
Waist-to-hip ratio
Men Women
,0.85 ,0.74 5,286 75 1.14 (0.85–1.53) 6,040 46 0.82 (0.55–1.21)
0.86–0.87 0.74–0.77 5,219 97 1.00 (Reference) 6,011 83 1.00 (Reference)
0.88–0.89 0.78–0.79 5,360 167 1.25 (0.96–1.62) 5,988 134 1.15 (0.87–1.51)
0.90–0.93 0.80–0.83 5,264 233 1.35 (1.07–1.70) 6,125 189 1.11 (0.88–1.40)
$0.94 $0.84 5,228 423 1.64 (1.30–2.07) 6,032 341 1.59 (1.27–2.00)
per SD (both sexes: 0.06) 26,357 995 1.22 (1.14–1.31) 30,196 793 1.27 (1.18–1.36)
Abbreviations: HR=hazard ratio, CI=confidence interval, SD=standard deviation.
aPersons with body mass index ,18.5 kg/m
2 were excluded from all analyses.
bAdjusted for age (in the time scale), smoking (never, former, current, unknown), physical activity per week (no, ,3 hours light, $3 hours light or ,1 hour hard,
$1 hour hard, unknown), and either body mass index or waist-to-hip ratio.
doi:10.1371/journal.pone.0026621.t008
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PLoS ONE | www.plosone.org 8 October 2011 | Volume 6 | Issue 10 | e26621It is hard to determine how much effort should be put into
training healthcare workers to measure WHR or WHtR in a
standardised and reproducible manner, as the potential for
predictive improvement will depend on the selected cut-off points
andalsothe choice ofpredictionmodel.In relation tocombined risk
algorithms [47,48], our results indicate that a NRI of up to 4%
might be reached for women and 1.5% for men, depending on cut-
off points, by replacing BMI with waist circumference, WHR or
WHtR. Identification of the most appropriate cut-offs for a given
prediction model could eventually be addressed in a future study.
Most preventive CVD guidelines [33,34,49,50] however do not
include markers of obesity in their combined risk algorithms.
Authoritative guidelines currently treat body composition/config-
uration as an isolated risk factor and usually lack clear specifications
regarding the numerical impact on disease risk. As long as this
approach is recommended for use in clinical practice, we argue for
the use of the anthropometric measure with the best predictive
properties. From this perspective, it appears rational to replace BMI
by WHR or WHtR when evaluating CVD mortality risk.
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